Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
NCT05798533
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
BIOLOGICAL:
Neo-T
COMBINATION_PRODUCT:
Toripalimab
COMBINATION_PRODUCT:
Tislelizumab
Sponsor
BGI, China
Collaborators
[object Object]
[object Object]